Literature DB >> 22826250

Human cytomegalovirus latency alters the cellular secretome, inducing cluster of differentiation (CD)4+ T-cell migration and suppression of effector function.

Gavin M Mason1, Emma Poole, J G Patrick Sissons, Mark R Wills, John H Sinclair.   

Abstract

After primary infection, human cytomegalovirus (HCMV) persists as a life-long latent infection, with host immunosuppression often resulting in clinical reactivation. During lytic infection, major changes in the expression of secreted cellular proteins (the secretome) occur that have profound effects on host-cell interactions, particularly at the level of the host immune response. In contrast, little is known about changes in the secretome that accompany latent infection, yet this is likely to be of major importance for the life-long carriage of this persistent human pathogen in the face of constant immunosurveillance. We have analyzed the secretome of cells carrying latent HCMV and have identified changes in several secreted cellular proteins known to be involved in regulation of the immune response and chemoattraction. Here, we show that a latency-associated increase in CC chemokine ligand (CCL)8 results in the recruitment of cluster of differentiation (CD)4(+) T cells to supernatants from latently infected CD34(+) cells but that these latent supernatants, also rich in immunosuppressive factors, inhibit cytokine secretion and cytotoxicity of HCMV-specific T-helper (Th)1 CD4(+) T cells. These results identify a strategy by which sites of latent HCMV can firstly recruit CD4(+) T cells and then inhibit their antiviral effector functions, thereby aiding the maintenance of latent infection in the face of the host immune response.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22826250      PMCID: PMC3437838          DOI: 10.1073/pnas.1204836109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  UL84-independent replication of human cytomegalovirus strain TB40/E.

Authors:  David J Spector; Kristen Yetming
Journal:  Virology       Date:  2010-09-19       Impact factor: 3.616

Review 2.  Murine models define the role of TGF-beta as a master regulator of immune cell function.

Authors:  J J Letterio
Journal:  Cytokine Growth Factor Rev       Date:  2000 Mar-Jun       Impact factor: 7.638

3.  Functional role of CD105 in TGF-beta1 signalling in murine and human endothelial cells.

Authors:  Kelly Warrington; M Chantal Hillarby; Chenggang Li; Michelle Letarte; Shant Kumar
Journal:  Anticancer Res       Date:  2005 May-Jun       Impact factor: 2.480

4.  Viral gene expression during the establishment of human cytomegalovirus latent infection in myeloid progenitor cells.

Authors:  Allen K L Cheung; Allison Abendroth; Anthony L Cunningham; Barry Slobedman
Journal:  Blood       Date:  2006-08-24       Impact factor: 22.113

Review 5.  Human chemokines: an update.

Authors:  M Baggiolini; B Dewald; B Moser
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

6.  TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance.

Authors:  Dori A Thomas; Joan Massagué
Journal:  Cancer Cell       Date:  2005-11       Impact factor: 31.743

7.  Viral interleukin-10 expressed by human cytomegalovirus during the latent phase of infection modulates latently infected myeloid cell differentiation.

Authors:  Selmir Avdic; John Z Cao; Allen K L Cheung; Allison Abendroth; Barry Slobedman
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

8.  Inhibition of epidermal growth factor receptor (EGFR) expression by human cytomegalovirus correlates with an increase in the expression and binding of Wilms' Tumour 1 protein to the EGFR promoter.

Authors:  Insiya Jafferji; Mark Bain; Christine King; John H Sinclair
Journal:  J Gen Virol       Date:  2009-03-25       Impact factor: 3.891

9.  HCMV IL-10 suppresses cytokine expression in monocytes through inhibition of nuclear factor-kappaB.

Authors:  James Nachtwey; Juliet V Spencer
Journal:  Viral Immunol       Date:  2008-12       Impact factor: 2.257

10.  Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL.

Authors:  Nagendra R Hegde; Claire Dunn; David M Lewinsohn; Michael A Jarvis; Jay A Nelson; David C Johnson
Journal:  J Exp Med       Date:  2005-10-10       Impact factor: 14.307

View more
  51 in total

Review 1.  Viral manipulation of the host immune response.

Authors:  Allison Christiaansen; Steven M Varga; Juliet V Spencer
Journal:  Curr Opin Immunol       Date:  2015-07-10       Impact factor: 7.486

2.  Mechanisms modulating immune clearance during human cytomegalovirus latency.

Authors:  Barry Slobedman; Edward S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

3.  Human Cytomegalovirus Requires Epidermal Growth Factor Receptor Signaling To Enter and Initiate the Early Steps in the Establishment of Latency in CD34+ Human Progenitor Cells.

Authors:  Jung Heon Kim; Donna Collins-McMillen; Jason C Buehler; Felicia D Goodrum; Andrew D Yurochko
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

4.  Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro.

Authors:  Vanessa M Noriega; Kester K Haye; Thomas A Kraus; Shanna R Kowalsky; Yongchao Ge; Thomas M Moran; Domenico Tortorella
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

Review 5.  The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?

Authors:  Mark R Wills; Emma Poole; Betty Lau; Ben Krishna; John H Sinclair
Journal:  Cell Mol Immunol       Date:  2014-08-18       Impact factor: 11.530

6.  Human cytomegalovirus G protein-coupled receptor US28 promotes latency by attenuating c-fos.

Authors:  Benjamin A Krishna; Monica S Humby; William E Miller; Christine M O'Connor
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-15       Impact factor: 11.205

7.  The myeloid transcription factor GATA-2 regulates the viral UL144 gene during human cytomegalovirus latency in an isolate-specific manner.

Authors:  Emma Poole; Anett Walther; Kathy Raven; Christopher A Benedict; Gavin M Mason; John Sinclair
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

8.  Expression of the human cytomegalovirus UL11 glycoprotein in viral infection and evaluation of its effect on virus-specific CD8 T cells.

Authors:  Ildar Gabaev; Endrit Elbasani; Stefanie Ameres; Lars Steinbrück; Richard Stanton; Marius Döring; Tihana Lenac Rovis; Ulrich Kalinke; Stipan Jonjic; Andreas Moosmann; Martin Messerle
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

Review 9.  Cytomegalovirus latency and reactivation: recent insights into an age old problem.

Authors:  Liane Dupont; Matthew B Reeves
Journal:  Rev Med Virol       Date:  2015-11-17       Impact factor: 6.989

10.  Human Cytomegalovirus-Encoded Human Interleukin-10 (IL-10) Homolog Amplifies Its Immunomodulatory Potential by Upregulating Human IL-10 in Monocytes.

Authors:  Selmir Avdic; Brian P McSharry; Megan Steain; Emma Poole; John Sinclair; Allison Abendroth; Barry Slobedman
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.